Henderson, A., Paterson, D. L., Chatfield, M. D., Tambyah, P. A., Lye, D. C., De, P. P., Lin, R. T. P., Chew, K. L., Yin, M., Lee, T. H., Yilmaz, M., Cakmak, R., Alenazi, T. H., Arabi, Y. M., Falcone, M., Bassetti, M., Righi, E., Rogers, B. A., Kanj, S. S., Bhally, H., Iredell, J., Mendelson, M., Boyles, T. H., Looke, D. F. M., Runnegar, N. J., Miyakis, S., Walls, G., Khamis, M. A. I., Zikri, A., Crowe, A., Ingram, P. R., Daneman, N., Griffin, P., Athan, E., Roberts, L., Beatson, S. A., Peleg, A. Y., Cottrell, K., Bauer, M. J., Tan, E., Chaw, K., Nimmo, G. R., Harris-Brown, T., Harris, P. N. A., & , (2021). association Between Minimum Inhibitory Concentration, Beta-lactamase Genes and Mortality for Patients Treated With Piperacillin/Tazobactam or Meropenem From the MERINO Study. Clinical infectious diseases, 73, e3842–e3850. http://access.bl.uk/ark:/81055/vdc_100148044544.0x000031